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Nanoemulsions are very interesting systems as they offer capacity to encapsulate both hydrophilic 
and lipophilic molecules in a single particle, as well as the controlled release of chemical moieties 
initially entrapped in the internal droplets. In this study, we propose a new two-step modified 
ultrasound-assisted phase inversion approaches-phase inversion temperature (PIT) and self-
emulsification, to prepare stable o/w nanoemulsions from a fully water-dilutable microemulsion 
template for the transdermal delivery of loratadine (a hydrophobe and as Ostwald ripening 
inhibitor). Firstly, the primary water-in-oil microemulsion concentrate (w/o) was formed using 
loratadine in the oil phase (oleic acid or coconut oil) and Tween 80  in the aqueous phase and by 
adjusting the PIT around 85 °C followed by stepwise dilution with water at 25 °C to initiate the 
formation the nanoemulsions (o/w). To assure the long-term stability, a brief application of low 
frequency ultrasound was employed. Combining the two low energy methods resulted in 
nanoemulsions prepared by mixing constant surfactant/oil ratios above the PIT with varying water 
volume fraction (self-emulsification) during the PIT by stepwise dilution. The kinetic stability was 
evaluated by measuring the droplet size with time by dynamic light scattering (DLS). The droplet 
size ranged 15-43 nm and did not exceed 100 nm over the period of over the 6 months indicating 
the system had high kinetic stability. Cryo-TEM showed the nanoemulsions droplets were 
monodispersed and approaching micellar structure and scale. All nanoemulsions had loratadine 
crystals formed within 20 days after preparation, which inclined to sediment during storage. 
Nanoemulsions improved the in vitro permeation of loratadine through porcine skin up to 20 times 
compared to the saturated solution. 
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Microemulsions and nanoemulsions attract interest as delivery systems for different moieties. 
They demonstrate droplet radii up to 500 nm with optimal system stability when the droplet size 
is less than 100 nm (McClements, 2012).  
A major drawback with microemulsions is the high surfactant and/or co-surfactant composition, 
which may make them potentially toxic upon administration. Therefore nanoemulsions can be an 
alternative as they share most of the good qualities of microemulsions- (apart from being 
thermodynamically unstables) - and can be formed at surfactant concentrations lower than required 
in microemulsions.  
One important aspect in the fabrication of nanoemulsions is the application of external energy to 
break the kinetic energy barrier of the immiscible components (oil and water). The energy applied 
should exceed the positive free energy of oil and water while in contact and the use of low 
frequency ultrasound (20 kHz) is justified by its ability to generate the required intense disruptive 
forces exceeding the forces that hold the droplets into spherical shape (Leong et al., 2009). The 
particle size of nanoemulsions tends to decrease as the ultrasonic intensity increases and tend to 
be more stable and less polydispersed with the use of ultrasound.  
One major drawback of high-energy methods is that less than 0.1% of the mechanical energy is 
utilized for the emulsification (Tadros et al., 2004). Thus, the use of low-energy is an alternative, 
which employs the intrinsic physicochemical properties of the emulsion components.  
Phase inversion temperature (PIT) was firstly reported by Shinoda and Saito (1969) which depends 
on the surfactant’s solubility changing from aqueous to oily phase with temperature and involves 
the mixing of oil, water and nonionic surfactant (such as polyethoxylated surfactants) at room 
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temperature with gentle stirring. A two-step process for the formation of finely dispersed 
emulsions for cosmetic use, with long-term stability, was described by (Wadle et al., 1993).  
One key aspect in the fabrication of nanoemulsions by PIT method is the utilization of high 
surfactant-to-oil ratio (SOR) to prepare the microemulsion base which will be used later to form 
the nanoemulsion by cooling and dilution at room temperature. The stability of nanoemulsions is 
a major challenge and are thermodynamically unstable even closer to the demixing line of 
microemulsions but kinetically stable systems (Delmas et al., 2011b). Factors such as the control 
of particle size distribution, the incorporation of stabilizers such as Ostwald ripening retarding 
agent or by using a suitable emulsifier type to prevent coalescence are employed to improve kinetic 
stability. 
It is reported that supersaturated vehicles can enhance drug absorption by the skin with high 
thermodynamic activity (Kemken et al., 1992). In this regard, microemulsions present a vehicle 
with decreasing water solubility for lipophilic molecules as the amount of water increases, which 
is the case during the preparation of nanoemulsion by the dilution method. Secondly, the drug 
incorporated within primary microemulsion can undergo in vitro crystallization very slowly after 
the preparation, which could take up to 10-14 days with no crystal observed within the first 2-3 
days after formation of the supersaturated systems (Kemken et al., 1992). 
The use of ultrasound-assisted phase inversion method will offer industrial benefits such as 
reduction in the amount of surfactants, easy manufacturing and processing of low-viscosity oil-in-
water nanoemulsions and short application of ultrasound that will produce a stable nanoemulsion. 
This will save the costs from applying high-energy ultrasound alone and will be more 
environmentally friendly and sustainable.      
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The aim of this work was to develop and characterize a stable nanoemulsion containing a saturated 
concentration of loratadine by ultrasound-assisted phase inversion method for transdermal drug 
delivery and investigate the effect of oil phase composition and surfactant concentration on the 
skin permeation of the drug. Loratadine was employed as a model ‘very lipophilic’ drug and to act 
as an Ostwald ripening inhibitor, which is reported for the first time. It is also the first time a 
nanoemulsion prepared by ultrasound-assisted two-step phase inversion and cooling-stepwise 
dilution method, loaded with near saturation concentration (Csat) of oil phase, with a drug molecule 
from w/o microemulsion for transdermal drug delivery.  
 
2. Materials and methods 
2.1 Materials 
Loratadine was kindly donated by Gulf Pharmaceutical Industries (Julphar, UAE). Oleic acid and 
orthophosphoric acid were purchased from Avonchem limited (UK). Coconut oil (chemically pure 
grade) was provided by Labchem products (USA). Tween 80, Tween 60, Span 60 and potassium 
phosphate monobasic were obtained from Sigma Aldrich Co. (USA) and of chemically pure grade. 
Tween 80 was of POE (20). Acetonitrile and methanol of HPLC grade were purchased from VWR 
BDH Prolabo Chemicals (UK). Water for HPLC was provided by Fisher Scientific (UK). Cellulose 
acetate dialysis membrane was obtained from HiMedia Laboratories Pvt. Ltd. (India). 
Polydimethylsiloxane membrane (PDMS) was purchased from Samco (UK). All other solvents 






2.2 Determination of loratadine solubility in lipids 
In preliminary experiments, it was found that a system composed of lipids other than oleic acid 
and coconut oil formed cloudy and unstable emulsions and they were discontinued from further 
investigations. In addition to that oleic acid and coconut oil were chosen due to their safety profiles, 
potential penetration enhancing activity and their use in cosmetic formulations (Viljoen et al., 
2015). These oils are relatively inexpensive and economically more readily available. 
To determine the solubility of loratadine in lipids, we adopted the method reported by Patel and 
co-workers (Patel et al., 2012). 50 mg of loratadine was transferred into a mortar maintained at 
temperature of 10 °C above the melting point of the lipid (~85 °C), and the lipid (oleic acid and 
coconut oil) was added gradually in increments of 50 mg and mixed, till loratadine was completely 
dissolved. The amount of lipid required to solubilize loratadine was noted by visualizing the 
disappearance of drug crystals and formation of a transparent homogeneous system and this was 
recorded (Cirri et al., 2018). 
 
2.3 Loratadine partitioning into lipids 
Partitioning behavior of loratadine between water and the lipids (oleic acid and coconut oil) was 
tested following the method reported by Venkateswarlu and Manjunath (2004) with slight 
modifications to mimic the experimental conditions needed for nanoemulsion production. This 
was performed by adding a known amount (10 mg) of loratadine to a mixture of equal volumes of 
hot distilled water and molten lipid. The mixture was shaken at 120 rpm for 2-4 hours in a hot 
water bath maintained at 10 °C above the lipid melting point (~85 °C) as previously reported by 
Joshi and Patravale, (2008) and Wong et al. (2004). Then the aqueous phase was separated after 
cooling by ultra-centrifugation at 25000 rpm for 20 minutes.  The drug content in the supernatant 
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was determined by HPLC-UV at 247 nm and the percentage of partitioning was calculated using 
the following formula: 
 
2.4 Formation of nanoemulsions  
A combination of low-energy (PIT) and high-energy (ultrasonication) techniques were employed 
to form nanoemulsions. A number of surfactants (Tween 80, Tween 60 and Span 60) were screened 
with different lipids (bees wax, carnauba wax, cetyl alcohol, coconut oil and oleic acid) in 
preliminary studies. Only coconut oil, oleic acid and Tween 80 were selected to proceed with 
further studies and three different ratios of lipid to surfactant 1:5, 1:7 and 1:10 were employed. 
The order of mixing was done by two methods named as ‘Method 1’ and ‘Method 2’. 
 
2.4.1 Method 1 
In Method 1, 75 mg of loratadine was dissolved in appropriate amount of oil (coconut oil and oleic 
acid) at 85 °C. The amount of oil added was based on loratadine solubility in the oil. Aqueous 
solution of Tween 80 was prepared separately and heated to the same temperature as the oil phase, 
then added drop wise to the lipid phase under homogenization with an Ultra-Turrax® homogenizer 
(IKA T25, Germany) at 14000 rpm for 5 min, to obtain a homogenous dispersion. Throughout the 
homogenization, the temperature was adjusted to 10 °C above the PIT. The PIT was determined 
using electrical conductivity measurements with rise in temperature and the cloud points in water 
and oil were visually defined. The resultant emulsion was subjected to sonication using a probe 
sonicator (300 V/T ultrasonic homogenizer, BioLogics Inc, USA) at a frequency of 20 kHz and 
power of 50% for 5 min with temperature maintained 10 °C above the PIT. Finally, the emulsion 
was rapidly diluted with water at room temperature under mild stirring using paddle stirrer at 500 
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rpm resulting in rapid formation of the nanoemulsions. The final ratio of nanoemulsion to aqueous 
media was 1:5 and the final water concentration was kept constant at 96-98%.  
 
2.4.2 Method 2 
The preparation in Method 2, was the same as in Method 1, however, the resultant emulsion was 
added drop wise to distilled water at room temperature using Ultra-Turrax® at 14000 rpm for 5 
min, to produce a nanoemulsion to aqueous media ratio of 1:5. Then the nanoemulsion was allowed 
to settle, and sonicated at room temperature using probe sonicator (300 V/T ultrasonic 
homogenizer, BioLogics Inc, USA) at a frequency of 20 kHz and power of 70% for 5 min. The 
final water concentration was kept constant at 96-98%. The effect of composition parameters, 
including the oil-to-surfactant weight ratio (O/S) and the droplet volume fraction (φ), was 
explored. The nanoemulsion components are defined by the following ratios: 
i. oil/surfactant weight ratio (O/S) = 100 × woil/(woil + wsurfactant) 
ii. droplet volume fraction (φ) = φoil + φsurfactant. 
 
2.4.3 Determination of cloud point 
The cloud points of 0.6, 0.84 and 1.2 wt % Tween 80 (C17H33) in water were determined by 
measuring the turbidity variation at 660 nm, as the temperature rose from 25 to 90 °C. The 
experiments (n = 3) were performed on a Litesizer 500 particle analyzer (Anton Paar, Austria) 
equipped with a Peltier temperature-control device, and the sample was measured using 1 cm 





2.4.4 Determination of PIT by turbidity measurements 
Turbidity measurements were used to determine the PIT of the nanoemulsions prepared using 
Methods 1 and 2 above. These systems were measured using Hellma quartz cuvette and subjected 
to a controlled heating/cooling cycle using Litesizer 500 particle analyzer (Anton Paar, Austria) 
fitted out with a Peltier temperature-control device. The samples were heated from 25 to 90 °C at 
5 °C / min, retained at 90 °C for 10 min, and then cooled from 90 to 25 °C at 5 °C / min. Turbidity 
versus temperature curves at 660 nm were plotted.  
 
2.4.5 Electrical conductivity measurements  
 
Electrical conductivity was used to determine the occurrence of phase inversion (i.e., from o/w to 
w/o or vice versa) during heating in the samples. A small amount of salt (7 mM NaCl) was added 
into the samples to increase their electrical conductivity. The samples were constantly mixed with 
the help of an Ultra-Turrax® homogenizer (IKA T25, Germany) during temperature-scanning 
electrical conductivity measurements (HANNA-HI 8733, USA). The emulsions were heated 
steadily using a temperature-controlled hot plate, and the conductivity was measured as a function 
of temperature upon the gradual addition of water. 
 
2.5 Nanoemulsions solubilization capacity 
Loratadine was added into the nanoemulsion vehicles to give a final concentration of 0.06-0.3 % 
(w/w), under continuous stirring at room temperature. The samples were held in tightly sealed 
glass vials and stored at room temperature for 48 h. Nanoemulsions with good capacity for 





2.6 Drug-loading and encapsulation efficiency 
Triplicate samples (n = 3) of nanoemulsions were ultra-centrifuged at 25000 rpm for 30 min and 
the obtained supernatant was analyzed using HPLC-UV. The following equations were used in 




High performance liquid chromatography (HPLC) was used to analyze loratadine. The stationary 
phase was Restec®, allure C18, 150 × 4.6 mm, 5μ, column (USA). The column temperature was 
maintained at 25 °C and the retention time was 3 min with injection volume of 20 μL. The mobile 
phase consisted of buffer (0.05 M monobasic potassium phosphate), acetonitrile and methanol 
(38:45:17 v/v) and the pH was adjusted with ortho phosphoric acid to 3.0 ± 0.2. The flow rate of 
the mobile phase was fixed at 1.0 mL min−1 and UV detection at 247 nm (Ramulu, 2011). A 
calibration curve was plotted from loratadine standards ranging from 2 µg/mL to 100 µg/mL (R2 
= 0.998). 
 
2.7 Particle size, polydispersity index (PDI) and zeta potential measurements  
Particles size measurements were determined using a Zetasizer Nano-ZS90 (Malvern Instruments, 
UK) laser diffraction instrument, using disposable sizing cuvette for size and PDI analysis. Zeta 
potential was measured using by measuring the surface charge using the same instrument with the 
help of a reusable folded capillary zeta cell, Malvern Model: DTS1070 at the Greenwich of 
University. The scattering angle was set at 173° and wavelength of 633 nm as required and 
analyses were carried out at 25 °C temperature. Samples were diluted before particle size and PDI 
11 
 
measurements, but zeta potential measurements were carried out without dilution. Particle size and 
PDI were used to evaluate the influence of SOR on nanoemulsion properties. All readings were 
determined in triplicates and the average values were calculated.  
 
2.8 In vitro release studies  
The effect of SOR on the loratadine release from the nanoemulsions was determined using Franz 
diffusion cells (V3A-02 PermeGear, USA) and to assess their release kinetics. Each cell had a 
surface area of 0.64 cm2 which was filled with 1 mL of nanoemulsion and a receptor compartment 
volume of 5.3 mL. The receptor compartment was filled with a hydroethanolic solution (1:1) to 
allow drug solubilization in the media and provide sink conditions and thermodynamic balance. 
The receptor medium was stirred with magnetic stirrer at 600 rpm and the temperature was 
maintained at 37 ± 0.5 °C by the use of a thermostatic water pump (Haake SC 100, Thermo Fisher 
Scientific, USA). The two compartments were separated by cellulose dialysis membrane (MWCO 
12-14 kDa, HiMedia Laboratories Pvt. Ltd., India) and the cellulose membrane exerts no resistance 
on particles moving across. The membrane was soaked overnight in distilled water prior to use, 
then cut to fit the surface area of Franz cell.  
The donor compartment was filled with 1 mL of the formulation, and was sealed with a taut layer 
of Parafilm M® to minimize evaporation. The release proceeded for 24 h in which 1 mL sample of 
receiver solution was withdrawn at predetermined time intervals and replaced with the same 
volume of fresh receptor media. The obtained samples were analyzed by HPLC-UV at 247 nm. 
The loratadine concentration values derived for each sample was corrected for the progressive 
dilution occurring during the course of the experiment. The experiments were performed in 
triplicates (n = 3) and the average values were calculated. The obtained release profiles were 
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compared by applying model dependent approach using Higuchi model, zero order and first order 
mathematical equations 
 
2.9 Skin preparation 
Frozen pig ears were used in the study and the external surface of the ear was sectioned 
horizontally by surgical scalpel under laminar airflow to obtain full thickness skin. The obtained 
skin was visually checked for integrity, cleaned and stored frozen at -18 °C until use within one 
month. Few hours before the permeation study, a piece of skin was allowed to thaw to room 
temperature, and then cut to smaller pieces that fit the surface area of Franz cell. The skin pieces 
were mounted on the Franz cell and allowed to hydrate for one hour before running the study. 
 
2.10 Pig skin permeation studies 
Hydroethanolic receptor medium (1:1) was mixed and sonicated for 5 min in an ultrasonic water 
bath to remove air bubbles and 5.3 mL was used to fill the receiver compartment in Franz diffusion 
cells. The donor compartment was filled with 1 mL of nanoemulsion sample. The media was 
stirred at 600 rpm with magnetic stirrer and temperature was maintained at 37 ± 0.5 °C. The skin 
membrane was mounted on the donor compartment to separate it from the receiver compartment. 
Franz cells were occasionally inverted to allow the escape of any air bubbles that had formed on 
the skins’ underside. 1 mL of the formulation was placed in the donor compartment of the Franz 
diffusion cell and sealed with a taut layer of Parafilm M® to minimize evaporation. The permeation 
studies were run for 24 h and the samples were analyzed using HPLC. Loratadine concentration 
values derived for each sample was corrected for the progressive dilution occurring during the 
course of the experiment. The experiments were performed in triplicates (n = 3) and the average 
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values were calculated. Amount of loratadine from the different formulations permeating the skin 
was compared to the permeation of saturated loratadine solution. 
 
2.11 Cryogenic-transmission electron microscopy (cryo-TEM) Imaging 
For cryo transmission electron microscopy studies, a sample droplet of 2ul was put on a lacey 
carbon filmed copper grid (Science Services, Muenchen, Germany resp. Quantifoil R2/2, 
Quantifoil Micro Tools GmbH, Jena, Germany), which was hydrophilized by air plasma glow 
discharge unit (30s with 50W, Solarus 950, Gatan, Munich, Germany). Subsequently, most of the 
liquid was removed with blotting paper in a Leica EM GP (Wetzlar, Germany) grid plunge device, 
leaving a thin film stretched over the lace holes in the saturated water atmosphere of the 
environmental chamber. The specimens were instantly shock frozen by rapid immersion into liquid 
ethane cooled to approximately 97K by liquid nitrogen in the temperature-controlled freezing unit 
of the Leica EM GP. The temperature was monitored and kept constant in the chamber during all 
the sample preparation steps. The specimen was inserted into a cryotransfer holder (CT3500, 
Gatan, Munich, Germany) and transferred to a Zeiss / LEO EM922 Omega EFTEM (Zeiss 
Microscopy GmbH, Jena, Germany). Examinations were carried out at temperatures around 95K. 
The TEM was operated at an acceleration voltage of 200kV. Zero-loss filtered images (DE = 0eV) 
were taken under reduced dose conditions (100 – 1000 e/nm2). All images were registered digitally 
by a bottom mounted CCD camera system (Ultrascan 1000, Gatan, Munich, Germany) combined 







2.12 Stability studies 
Formulations prepared with different lipids and surfactant ratios were stored in sealed clean glass 
vials at room temperature (25 °C) and at cold temperature (8 °C) for 6 months. The stored 
formulations were monitored and assessed periodically for particle size using Litesizer 500 (Anton 
Paar, Austria) and zeta potential changes, in addition to alterations in the physical appearance such 
as gelation, precipitation and drug crystallization. The surface coverage of oil drops by surfactant 
(Γ) was calculated using Langmuir isotherm model:  
 
where Γsat is the saturation adsorption, C is the surfactant concentration, and kd is the adsorption 
coefficient. As reported by Penfold et al. (2015) , Tween 80 (POE 20) has Γsat and kd values of 
1.4 x 10-10 mol cm-2 and 2.7 μM. 
 
2.13 Statistical analysis 
Quantitative data were obtained in triplicates (n = 3) and are reported as mean ± standard deviation. 
Statistical analyses were performed using Minitab version 14 software and analysis of variance 
(one- way ANOVA) and post hoc Tukey’s test were performed. A p value < 0.05 was considered 
statistically significant. 
 
3. Results and discussion  
3.1 Lipids screening 
Different lipids were screened for potential use in the preparation of nanoemulsions. In each 
experiment, different amounts of loratadine were dissolved incrementally in hot melted lipids to 
determine the amount of lipid required to solubilize the drug to its saturation solubility to achieve 
drug-enriched core nanoemulsions (Mishra et al., 2018) as shown in Table 1. Drug supersaturation 
15 
 
occurs during cooling of the nanoemulsion and causes precipitation of the drug before the 
precipitation of lipid. This results in the precipitating lipid to surround the precipitated drug, 
forming a membrane around incorporated drug (Mishra et al., 2018). Loratadine solubility was 
found to be maximum in stearic acid, followed by oleic acid, cetyl alcohol, stearyl alcohol, coconut 
oil, beeswax and carnuba wax. However, stearic acid, stearyl alcohol, cetyl alcohol and carnuba 
(data not published) failed to produce stable nanoparticles. 
The results were confirmed by the preparation of loratadine standard curve in ethanol/water (1:1) 
and measured at 247 nm. The drug is highly lipophilic (log Ko/w = 5.2) and it’s partitioning into 
lipids (oleic acid and coconut oil) was above 90%.  
Generally, o/w nanoemulsions are preferred for the solubilization of lipophilic molecules. It was 
reported that food-grade oils are not a good choice for the solubilization of large amounts of 
lipophilic drugs (Azeem et al., 2009). However, the amount of loratadine dissolved in oleic acid 
and coconut oil was 100 and 200 mg respectively. This is consistent with previous data reported 
by Tavares et al., (2016) and Song and Shin (2009) showed that 0.05 to 5.0% (w/w) of loratadine 
is preferred to penetrate the skin so as to achieve the desired therapeutic effect. In this study, 
nanoemulsions had loratadine concentrations from 0.06-0.3%, which are pharmaceutically 
acceptable.       
Mechanistically, Rane and Anderson (2008) suggested that highly lipophilic molecules 
predominantly dissolve in the oil phase compared to surfactant and water. This has an impact on 






3.2 Preparation of nanoemulsion  
Blank and drug loaded nanoemulsions were prepared by two methods which involved different 
order of mixing and homogenization using the lipids screened and Tween 60, Span 60 and Tween 
80 at three different ratios of lipid to surfactant 1:5, 1:7 and 1:10 and the composition for the 
various formulations are shown in Table 2. The amount of lipids was determined by the drug 
solubility in the lipids (Lopes, 2014) and the solubilization capacity of a given amount of surfactant 
to incorporate the maximum amount of oil (Rao and McClements, 2012). High amounts of lipids 
beyond 10% (w/w) increases the viscosity of the dispersion and decreases the efficiency of 
homogenization which leads to high particle size and PDI, resulting in particles agglomeration and 
therefore nanoemulsion instability (Mehnert W, 2001). The total amount of oil phase including the 
drug (CSat) in this study was 0.3-1.5% (w/w), to assure good solubilization capacity by surfactant, 
small particle size and long stability as well as to ensure the formation of transparent solutions 
(Rao and McClements, 2012). To achieve an optimal particle size, Tween 80 was chosen and its 
concentration determined based on the preliminary solubilization experiments taking into 




3.2.1 Phase behavior of nanoemulsion  
Based on the physical appearance, particle size, zeta potential and stability, formulations were 
optimized and further characterized. Initially, the physical appearance of the formulations were 
evaluated based on the visual clarity. A transparent to translucent liquid was considered as a 





Formulations prepared with Tween 60 and Span 60 were excluded due to the formation of white 
gel like structures. This gelation indicates limited solubilization capacity of Tween 60 and Span 
60 and may be attributed to the limited mobility of the lipid which prevents the surfactant from 
complete coverage of the particle interface (Blanco-Prieto et al., 2015). Only formulations with 
Tween 80 showed good physical appearance and stability.  
We characterized the phase behavior of would-be nanoemulsions depending on the electrical 
percolation threshold keeping in mind that the phase characterization provided here does not refer 
to the correct phase diagram due to the metastable characteristics of nanoemulsions and the 
conditions of the experiment. The samples were inspected after 2 and 7 days keeping in mind that 
samples could continue to evolve and change significantly with time.  
 
3.2.2 The effect of temperature and surfactant concentration on the cloud point  
Tween 80 (C17E20) is a polysorbitate with an ethylene oxide backbone of w + x + y + z= 20 
providing the hydrophilic nature. The oleate moiety (CnHn2n-1, C17H33) of polysorbate 80 contains 
a double-bond forming a kink in the hydrocarbon chain providing the hydrophobic nature. Tween 
80 has a CMC of 0.012-0.015 mM and the presence of additives may affect the temperature 
dependence of a nanoemulsion containing a CmEn surfactant. To asses this effect, the cloud point 
(CP) is used to determine the transition from a homogeneous micellar solution into two isotropic 
solution phases, one of which is rich in surfactant and the other is surfactant-poor, and is detected 
by an increase in the turbidity of the solution (Machado et al., 2012). Two scenarios are possible 
upon the use of additive. Firstly, if the CP of a CmEn surfactant increases, it means that the additive 
interacts with the surfactant aggregates, whereas a reduction in the CP suggests that the additive 
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is depleted from the micellar pseudo-phase (Machado et al., 2012). This behavior will be helpful 
in solubilizing lipophilic moieties through the generation of w/o phase. It is important to confirm 
the presence of this behavior during the formulation as it will have an impact on the PIT.     
The CP of all solutions of C17E20 in water was determined to be 90 °C (Fig. 2). Increasing the 
surfactant concentration showed more turbidity without a significant change in the CP. Shinoda 
and Arai (1964) reported that the longer the hydrophilic chain, the higher the CP. In addition to 
that, a change in the volume ratio of surfactant does not have much effect on the CP compared to 
the temperature effect.  
Figure 2 
3.2.3 Effect of oil and surfactant on the PIT 
The turbidity-temperature profiles of the surfactant-oil-water mixtures were measured when they 
were heated and then cooled in Liteszier 500 particle analyzer by measuring the %Transmission 
(Fig. 3). The samples demonstrated an appreciable drop in turbidity over the temperature range 
used in the experiment. The temperature at which turbidity first fell sharply during heating was 
considered as the PIT (Fig. 3). Compared to the CP temperature of 90 °C, the PIT was determined 
at 75 °C and confirmed that increasing hydrocarbon levels by the presence of oil decreases the CP 
(Shinoda and Arai, 1964). A marked decrease in turbidity was noted during cooling in the same 
samples and confirms the transition between w/o into o/w, passing through the bicontinuous 
microemulsion, which was confirmed by the conductivity measurements in the next section. 
Increasing surfactant concentrations had the same effect on the PIT as on the CP. This is useful to 
estimate the PIT from CPs of nonionic surfactants in the absence of hydrocarbons. Based on the 
data, the PIT emulsification process was kept at a constant temperature range between 75-85 °C 
to ensure the formation of bicontinuous microemulsion (Engels et al., 1995). At those high 
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temperatures, the interfacial tension decreases and the amount of surfactant molecules adsorbed at 
the o/w interface increases gradually until saturation is achieved (Yu et al., 2012). Cooling was 
done as part of phase inversion composition (PIC) method by the dilution of microemulsion with 
water to bring the temperature to 30 °C below the PIT to obtain nanoemulsions that are stable and 
avoid coalescence (Chuesiang et al., 2018).   
Figure 3 
3.2.4 The impact of water phase composition on phase inversion  
It is known that microemulsions generally have low conductivity but it is significantly higher than 
that of pure oils such as oleic acid and coconut oil. Increasing the temperature and/or varying the 
molar fraction of water at constant temperature of the microemulsion, initially results in a gradual 
rise in its conductivity, but once a certain point is reached, there is a sudden sharp rise due to 
electrical percolation (Moldes et al., 2016). 
The usual experiment involves adding water to an oil/surfactant mixture at constant temperature 
(PIT = 85 °C). A representative example of a typical conductometric experiment is reported in Fig. 
4 and three regions can be identified. Upon initial addition of water (< 10% H2O), there was an 
initial increase in conductivity which is attributed to hydration of the surfactant head groups and 
increasing their mobility (Chiappisi et al., 2016). As φw is additionally increased (~20% H2O), the 
first droplets of water in oil are formed in which loratadine gets solubilized, resulting in an overall 
decline in κ, where its peak decline indicates the start of the electrical percolation line. After 
another addition of water content at ~30% H2O, the microemulsion droplets swell until the initial 
concentrate of bicontinuous microemulsion is formed (Wang et al., 2008) and is represented by a 
sudden and sharp rises in κ, which indicates that the percolation has been threshold reached. The 
same transparent electrically conducting one-phase microemulsion was observed at 90 °C by 
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(Wadle et al., 1993). However, as soon as the phase transition to the nanoemulsion phase takes 
place and o/w nanoemulsions are formed, κ increases only moderately with increasing water 
(~70% H2O) which was characterized as single, slightly shining blue and milky nanoemulsions. 
Additional dilution leads to a clearing of the nanoemulsion due to reduction in the volume fraction 
of the dispersed material (Heunemann et al., 2011). 
The mechanism for the formation of nanoemulsion by PIC approach (Tirnaksiz et al., 2010) 
suggested the following events: (i) upon the first addition of water, water droplets will form in the 
continuous oil phase and (ii) further addition of water changes the spontaneous curvature of 
surfactant. The system starts as w/o microemulsion passing through bicontinuous structure, after 
which the water droplets merge and then decompose into smaller droplets upon further increase in 
the water content. From the point of view of phase inversion by temperature, raising the 
temperature leads to the dehydration of surfactant, triggering the formation of a w/o emulsion. 
Once the temperature decreases upon the addition of water, the bicontinuous microemulsion forms. 
Therefore, we propose that the two approaches augment each other to form a stable nanoemulsion 
in our experiment. 
The method proposed for the production of nanoemulsion involved a preparation of microemulsion 
template in which a substantially insoluble drug such as loratadine is totally soluble in the 
dispersed or internal phase with appropriate emulsifier such as Tween 80 and external phase with 
limited solubilizing activity. However, microemulsion has high concentrations of surfactant, 
rendering it not ideal for topical application due to low kinetic stability. Therefore, the formation 




Considering the influence of the compositions (i.e. surfactant; water and oil) on the appearance of 
bicontinuous structure, a ternary phase diagram is constructed for phase inversion feasibility 
domain (PIFD) at PIT (Anton et al., 2008). The domains included all compositions, which do, or 
do not, exhibit a peak of electrical conductivity. All the generated nanoemulsions in this study, 
showing droplet diameters below 100 nm exhibited conductivity. The results confirm the presence 
of bicontinuous structure where higher concentrations of surfactant were present as observed by 
Anton et al. (2008).  
It was also observed that increasing surfactant concentration resulted in an increase in the 
nanoemulsion region (Fig. 5). All formulations prepared from phase diagrams that expanded the 
nanoemulsion region to an aqueous-rich apex could be diluted to a greater extent. 
Figure 5 
 
To ensure that the formation of microemulsion with small initial particle size, was relatively low 
below 40 nm, high surfactant content (ranging from 3-12% w/w) was used in some preparations 
(Pons et al., 2003). Small particle size of microemulsion may be attributed to the structure of the 
initial phase as the dilution involved the oil droplets that were already present without the need for 
the transformation from the bicontinuous structure to the closed oil structures (Pons et al., 2003).  
In both methods of preparation, the nanoemulsion was prepared by a two-step phase inversion that 
involved water dilution at the in the final stage, in a proportion of 1:5 (final water concentration 
was at 96-98%) to form the nanoemulsion. Well-defined phase inversion methods previously 
reported did not use total amount of surfactant above 10% (Tirnaksiz et al., 2010). Smaller particle 
size was also linked to higher water content, and thus offer better stability (Solè et al., 2012). The 
dilution is important for two reasons, firstly microemulsions have high concentration of surfactant 
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(up to 15% in our experiments) which is not favorable from the regulatory point of view (Chen et 
al., 2015) and secondly to ensure the formation of nanoemulsions with good kinetic stability 
(Wooster et al., 2008).   
However, the order of mixing had no significant effect (p > 0.05) on the particle size, in method 
1, with the particle size increasing as the surfactant concentration increased in contrast to method 
2 in which the particle size decreased as the surfactant increased. In both methods, the droplet size 
appeared to be constant within 20% of water dilution. The findings are consistent with data 
reported by Solè et al. (2012) and showed the particle size is independent of the dilution of the 
microemulsion. The data showed that the use of phase inversion emulsification method at 80 - 95 
w/w % water can result in the formation of emulsions with droplet size below 40 nm and 
independent of the water content as reported by Morales et al.(2003). It was suggested that the 
mechanism of nanoemulsion formation requires complete solubilization of the oil phase in a 
bicontinuous microemulsion before dilution with water (Morales et al., 2003). 
The use of ultrasound in the nanoemulsions proved efficient in producing nanosystems having 
very small diameters with low energy consumption as it provides sufficient shear rate (Delmas et 
al., 2011a). It is also important to note that the production of nanoemulsions-after the 
microemulsion formation- requires energy input to overcome the oil/water interfacial tension 




3.2.5 The effect of shear 
 
We suggested the use of Ultra-Turax homogenizer instead of simple mechanical stirring in this 
method because this would create a high hydrodynamic shear tool around or above the PIT in order 
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to extend the microemulsion or bicontinuous structure domains and to ensure all the oil phase was 
completely solubilized, therefore yielding a fairly monodispersed system (Roger et al., 2010). In 
our study, we did not obtain nanoemulsions having smaller droplets size below 100 nm when we 
used simple mechanical stirring compared to Roger et al. (2010) because the O/S ratio used was 
low (0.2-0.1). However, this can be considered as an advantage of forming a stable nanoemulsion 
at low surfactant concentration.   
 
3.3 Loratadine entrapment in nanoemulsions  
Loratadine entrapment was analyzed using HPLC and the EE in nanoemulsions ranged from 99.30 
% to 65.02 % as shown in Table 4. For the same surfactant ratio, changing the lipid type had 
significant effect (p < 0.05) on drug entrapment. It is noteworthy that the amount of loratadine in 
all formulations was set at the saturated level shown in Table 1, because beyond these 
concentrations, nanoemulsions will break. Nanoemulsions with oleic acid showed better drug 
loading and it can be explained that the amount of oleic acid is enough to solubilize loratadine 
compared to the amount of coconut oil. It is important to note that we tried to increase the amount 
of oil (data not shown) to solubilize the drug but the resultant nanoemulsions were not stable. 
The solubilization capacity was generally high for any water content at higher temperature. As the 
temperature increased the solubility of the ethoxylated surfactant decreased and which is because 
the mixture will be hydrophobic so that its packing at the interface will be looser, allowing more 
drug molecules to be integrated at the interface (Garti et al., 2006). 
However, DL noticeably decreased with surfactant concentration increases and this may be 
attributed to the higher surface coverage of droplet (Table 3) by the surfactant that may lead to 
more packing (less space) of the surfactant and hindering the drug encapsulation to some extent 





3.4 Influence of oil type and surfactant concentration on the mean droplet diameter and particle 
size distribution  
Table 5 shows particle size measurement, PDI and zeta potential of nanoemulsions using dynamic 
light scattering technique, which measures the fluctuations of scattered light intensity caused by 
particles movement. It can cover particle size ranges from a few nanometers to about 3 microns. 
One characteristic feature of this technique is smaller particles result in more intense light 
scattering compared to larger once. In general, the results showed that the mean droplet diameter 
remained below < 45 nm regardless of the oil used (p > 0.05).  
Anton Vandamme (2009) reported that nanoemulsion parameters such as particle size, 
polydispersity index (PDI) and droplet concentration are linked to proportion of different 
components of nanoemulsion. 
Table 5 
In terms of surfactant concentration, it was expected that increasing surfactant content would 
improve oil solubilization of nanoemulsion droplets. In Method 1, the particle diameter relatively 
increased as the surfactant concentration increased (Guttoff et al., 2015). This may be attributed to 
the order of mixing which involved the preheating of oil and water phases under Ultra-Turax 
homogenization, followed by ultrasonication and dilution with water. The use of high surfactant 
concentration can help the transport of nanoemulsion droplet via micelles, which may drive droplet 
growth by Ostwald ripening and coalescence (Rao and McClements, 2012). 
In contrast, Method 2 showed the opposite behavior with increased concentration of surfactant, 
where particle size decreasing as the surfactant concertation increased (Guttoff et al., 2015); which 
may be attributed to the order of mixing which involved the preheating of oil and water phases 
followed by dilution with Ultra-Turax homogenization and followed by ultrasonication.  
3.5 The effect of ultrasound  
Ultrasound might have helped to overcome the influence of high surfactant concentration on 
droplet growth by reducing the contact between the nanoemulsion droplets and micelles as 
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suggested by Rao and McClements (2012). The application of ultrasound is known to form 
nanoemulsions of small particle size with narrow distribution by two mechanisms not offered by 
other mechanical devices-, which are (a) droplet disruption and (b) droplet coalescence. The 
former mechanism is governed by the type and amount of shear force applied to droplets and their 
resistance to deformation which is determined by the surface tension (Li and Chiang, 2012). The 
latter mechanism, droplet coalescence, results from the surfactant’s capacity to adsorb onto the 
surface of newly formed droplets. This depends on the surface activity and concentration of the 
surfactant (Li and Chiang, 2012). 
In light of the aforementioned mechanisms, Method 1 was performed by the application of 
ultrasound on heated undiluted emulsion during the phase inversion (w/o to bicontinuous structure) 
by temperature approach (step 1). At this point, the amount of shear force applied to droplets 
(droplet disruption) was less efficient to disrupt the droplets, as the propagation medium of 
ultrasonic waves is predominantly oil. As a result, the droplet coalescence mechanism will prevail 
and surfactant adsorption ability decreases, which triggers more coalescence even in the presence 
of higher Tween 80 concentrations. 
On the other hand, in Method 2, the emulsion was first diluted at a temperature above the PIT and 
then sonicated. This allowed the system to invert from a w/o to an o/w nanoemulsion upon dilution 
and offering the ultrasound waves a better medium to propagate and disrupt the droplets. In the 
presence of high surfactant concentration and surface activity of 100% (Table 3), the nanoemulsion 
will give high surfactant adsorption capacity and prevent particles from coalescing. 
Ultrasonic time is a significant parameter for the thermodynamic equilibrium in an o/w emulsion 
and influences the rate of adsorption of surfactants to the droplet surface and the size distribution 
of newly formed droplets. Larger droplets are formed during longer ultrasonic time (> 5 min) and 
which could be ascribed to the impact of emulsification over-processing, leading to the droplets 
coalescence (Li and Chiang, 2012). 
One important advantage of our proposed method is the controlling of the system’s viscosity via 
temperature and composition with the application of ultrasound for a short time (5 min) to form 
stable nanoemulsions. However, in both methods, formulations with various concentrations of 
surfactant, did not show significant change in the particle size (p > 0.05) and did not exceed 45 nm 
at any water content above 90% as demonstrated by Garti et al. (2016). In this study, the effective 
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hydrodynamic diameter of Tween 80 micelles was 10.35 ± 0.64 nm and is in agreement with the 
value determined by Karjiban et al. (2012) which was between 2.8-6.4 nm. The use of oleic acid 
and coconut oil increased the particle size to about 45 nm suggesting the oil insertion between the 
surfactant tails rather than forming a core within the micelles. This is in good agreement with data 
reported by Rao and McClements (2012). 
 
3.6 The effect of dilution  
In terms of water dilution, the particle size did not change by changing the droplet volume fraction 
as excess water acted only as dilution medium (Yu et al., 2012; Morales et al., 2003). It was 
reported that the initial droplet size is dictated by bicontinuous phase structure during the phase 
inversion-induced by either temperature or composition (Yu et al., 201 2; Solè et al., 2012).  
The reason for rapid cooling-dilution is that extensive droplet coalescence occurs when the systems 
spend more time in the droplet coalescence zone during slow cooling-dilution (Saberi et al., 2015). 
The temperature of water for dilution was set at 25 °C because our preliminary experiments 
showed that dilution at 15 °C promoted gelation similar to results reported by Rao and McClements 
(2010). Studies have shown that stable o/w emulsions with small droplets can be obtained using 
the PIT method when the difference was 20-65 °C below the PIT (Shinoda and Saito, 1969). In 
our study, the optimum temperature (25 °C) for surfactant/oil/water system used was about 60 °C 
below the PIT. This will be indicative to predict optimal storage temperature (Rao and 
McClements, 2010).  
Figs. 6a & b showed the effect of oil on the particle size distribution using oleic acid and coconut 
oil. Unimodal distribution of small particles of oleic acid around 50 nm was observed, which 
suggests that all oil phase droplets had dissolved and formed swollen micelles (Fig. 6a). In the case 
of coconut oil used (Fig. 6b), a multimodal distribution was noticed with a population of small 
particles around 15 nm and confirms the formation of nanoemulsion. In addition, a population of 
large particles were observed around 500 nm, which may suggest the presence of swollen micelles 
and undissolved nanoemulsion droplets. This is consistent with observation reported by Rao and 
McClements (2012) and indicates that the critical oil concentration of the drug used was almost 
reached (~ Csat).  
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It is also worth mentioning that the viscosity of oils used could dictate the droplet size distribution 
of nanoemulsions during formation and upon storage (Wooster et al., 2008). At the PIT, the 
viscosities of oleic acid and coconut oil are reduced to about 5.61 and 7.55 cP from 17.7 and 28 
cP at 37 °C (Noureddini et al., 1992).  
Figure 6 a & b 
This reduction in viscosity at PIT with the optimization of surfactant concentration can lead to the 
formation of small nanoemulsions (Wooster et al., 2008) and this was  observed in our study, for 
nanoemulsions prepared from coconut oil with various surfactant concentrations.  
It is also important to note that the purity of nanoemulsion components has a role on the phase 
behavior investigations. For example, the response to temperature of technical grade surfactants 
could be entirely different from that of the pure system because the partition of surfactant 
counterparts between water and oil is distinct from each other (Yu et al., 2012).       
Small particle size has an impact on the drug permeation through stratum corneum (SC) by 
shortening the lag time. Choi and Maibach (2005) reported that the SC has small virtual pores in 
the range of 20 nm to 40 nm. Polydispersity index is a measure of distribution of the molecular 
mass in a given sample. PDI values > 0.7 indicates that the sample has broad range of particle size 
distribution, while values < 0.05 are rarely seen and cannot be considered for estimation, however, 
PDI < 0.3 has been considered an ideal monodispersed system. A polydispersed system is at risk 
of particle size growth due to Ostwald ripening in which smaller particles with high surface energy 
adhere to larger particles to form an energetically more stable system. The nanoemulsions had a 
PDI ranging from 0.19 to 0.4. This indicates that the nanoemulsions had a narrow size distribution, 
and suggests the monodispersity of the system which reflects positively on the system stability. In 
some cases, there was a slightly broad range of particle size distribution, which is a known 
drawback to implementing ultrasound as a tool for particle size reduction (Naseri et al., 2015). It 
was observed that there was a slight increase of the PDI, which might be ascribed to the weak 






3.7 In vitro drug release studies  
All formulations showed an initial burst release of loratadine which can be attributed to drug 
movement from the drug enriched shell core (Figs. 7a & b) and the drug enriched shell core 
formation can be explained by the mechanism of lipid precipitation during cooling. After hot 
homogenization, each droplet is a combination of lipid and drug. Cooling accelerates lipid 
precipitation at the core and raises the drug concentration in the outer liquid lipid and complete 
cooling produces shell core enriched with the drug. This structural model and its rapid release are 
suitable for dermatological formulations that are intended for increased drug permeation. It is also 
possible that high surfactant concentration resulted in the burst release of loratadine (Mishra et al., 
2018). 
Results showed a release of 54% to 83% over a period of 24 h, as shown in Figs. 7a and b. The 
low release profile for some of the formulations can be attributed to the low aqueous solubility of 
loratadine and the structural integrity of the lipid which makes the drug take longer time to diffuse 
out from the inner core to the outer medium. 
Statistically, there were no significant effects (p > 0.05) on drug release because of oil phase 
composition, surfactant concentration and the method of preparation, except when the oil phase 
composition from oleic acid to coconut oil changed at constant 1:10 ratio of Tween 80, where it 
showed a significant effect (p < 0.05) on the drug release for both methods (1 and 2), which could 
influence the drug permeation through the skin. This might be attributed to the increased packing 
of Tween 80 as its concentration increases (Kogan et al., 2008) as well as the viscosity of coconut 
oil compared to oleic acid, which both hinder the drug release from the system.  
To investigate the drug release behavior, kinetic modeling was performed to predict the rate and 
the mechanism of drug release. The drug release from nanoemulsions was best fitted (R2 = 0.993) 
to zero order kinetic model as they showed highest R2 values compared to other kinetic models 
(first order, Higuchi and Korsmeyer-Peppas). It means that drug release is independent of the 
amount of drug remaining in the formulation and this behavior was also noted by Djekica’s group 
(2012) from microemulsion formulations. 




3.8 Skin permeation studies 
The permeation of nanoemulsions was examined using porcine skin and compared to the 
permeation of loratadine aqueous saturated solution. Loratadine aqueous saturated solution 
showed very low flux in the skin (0.09 µg/cm2/h) while all the nanosystems showed an enhanced 
permeation with varying enhancement ratios. Cumulative amount of loratadine permeated after 24 
h through pig skin from nanoemulsions prepared with oleic acid as oil phase showed an increase 
in the enhancement ratio with increasing surfactant concentration and decreased as the surfactant 
increased. This was observed with oleic acid nanoemulsion (OA-5), where the ER was 41.3 times, 
with flux equal to of 3.75 µg/cm2/h which was significantly higher (p < 0.05) compared to the 
permeation from the aqueous saturated solution (Fig. 8a).  
OA-7 and OA-10 nanoemulsions showed a decreasing ER of 11.5 and flux of 1.05 µg/cm2/h, and 
19.6 and a flux of 1.78 µg/cm2/h respectively and the permeation was not significant between OA-
7 and OA-10 (p > 0.05). This is consistent with the work by Yuan et al. (2010) who reported that 
there is a plateau surfactant concentration beyond which the drug permeation will decrease. As a 
result, there was only a minor effect of surfactant concentration on the mass transfer coefficients 
in oleic acid nanoemulsions. These formulations also had the highest EE%, which is one of the 
factors affecting permeation.  
The same behavior was observed when coconut oil was used as an oil phase. Fig. 8b showed no 
significant difference between the resultant fluxes (p > 0.05) and this may be attributed to the 
insignificant difference (p > 0.05) among the obtained particle sizes for these formulations. CO-5 
flux was 0.65 µg/cm2/h followed by 0.58 µg/cm2/h and 0.25 µg/cm2/h for CO-10 and CO-7 
respectively while the enhancement ratios were 7.1, 2.7, and 2.1 respectively. Changing the 
surfactant ratio did not show any significant enhancement in loratadine permeation (p > 0.05) 
which means the possible penetration enhancement effect of Tween 80 is not mainly responsible 
for the improved skin delivery neither had a significant effect on particle size. In contrast, 
increasing Tween 80 concentration in both oils reduced the drug permeation which might be 
attributed to the increased packing of surfactant as its concentration increases and in turn hinder 
the drug release from the system (Kogan et al., 2008).  
Nanoemulsions prepared with coconut oil generally showed less permeation in comparison to 
those made with oleic acid. This may be due to the structure of coconut oil consisting of higher 
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levels of short chain saturated fatty acids such as lauric acid (makes up about 50% of the fatty 
acids in coconut oil). These fatty acids have insufficient lipophilic characteristics to actively 
permeate the stratum corneum, thus, rendering poor penetration (Viljoen et al., 2015). These sets 
of nanoemulsions with coconut oil of moderate permeation enhancement compared to oleic acid 
proved that the latter has a role in improving the loratadine permeation through the skin. Oleic acid 
exerts its penetration enhancing activity via a distinctive feature of cis double bond at C9 which 
bends the alkyl chain and disturbs the SC lipid bilayers (Abd et al., 2018).  
Figure 8 a & b 
  
Moreover, nanoemulsions with oleic acid showed high loading capacity (near saturation) 
compared with coconut oil nanoemulsions. This observation is consistent with the work done by 
Land et al.(2006) who reported that systems with near saturation leads to a great enhancement in 
mass transport. This near saturation may undergo supersaturation from microemulsions during 
occluded application and forms an additional driving force with small nanoparticles as reported by 
Kemken et al. (1992). It was also observed that drugs tend to become supersaturated in the 
microenvironment upon dilution and grow into crystals (Aserin and Garti, 2005). We suggest that 
this effect plays a pivotal role in enhancing the drug permeation from those nanoemulsions 
containing oleic acid at high surfactant concentrations (OA-7 and OA-10) and coconut oil 
nanoemulsions (CO-5, CO-7 and CO-10).         
However, all nanoemulsions showed improved skin drug permeation in vitro that can be via 
different mechanisms and loratadine crystallization in nanoemulsions does not affect drug 
permeation. There are three potential mechanisms for increased delivery of loratadine from 
nanoemulsions as suggested by Abd et al. (2018): (i) increased solubility of the drug in the applied 
nanoemulsions; (ii) improved uptake of the vehicle carrying the drug into the SC; and (iii) a direct 
impact on the SC membrane properties, such as enhanced fluidization of the SC lipids. 
Additionally, permeation rates tend to be very high from supersaturated vehicles.   
Loratadine is practically insoluble in water (0.0134 mg/mL) (DrugBank, 2019). The solubilization 
capacity of loratadine substantially increased to 45 times in the nanoemulsion formulations 
containing a combination of oil phase (oleic acid and coconut oil), surfactant, and aqueous phase 
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compared to the saturated aqueous solution. This effect was pronounced with oleic acid 
nanoemulsions than the one noted with coconut oil due to the high solubility of loratadine in oleic 
acid nanoemulsions and this increased solubility had an impact on the nanoemulsion uptake into 
the SC.   
Another strategy to explore the enhancement mechanisms of skin permeation was to determine the 
Jmax, the maximum flux of the aqueous saturated solution, as it is known that Jmax  depends only on 
the thermodynamic activity of the solute in the vehicle, provided the vehicle or solute does not 
change the membrane characteristics (Zhang et al., 2013). It is noted that the Jmax value was low 
for the aqueous saturated solution of loratadine (Figs. 8a & b), however, in contrast, Jmax values 
for nanoemulsions were much greater than for control. This proves that the nanoemulsions 
changed the SC barrier properties. It is well known that oleic acid and lauric acid (main component 
of coconut oil) enhance skin permeation by disrupting SC lipid (Osborne et al., 1991).  
             
3.9 Cryogenic TEM observation of nanoemulsions 
The appearance of nanoemulsions was translucent to the naked eyes as shown in Fig. 1. Cryogenic 
TEM was used to observe the droplet size in the nanoemulsions and the size was correlated with 
the data obtained from droplet size analysis using light scattering. Cryogenic TEM showed short 
features visible which can be described as parts of small vesicles or intact vesicles in the range of 
50 nm. In addition, there were only small micelles in the range of 10-20 nm and were monodisperse 
(Aserin and Garti, 2005), thus confirming the hydrodynamic diameter of micelles obtained by DLS 
in section 3.4 as shown in Figs. 9a & b. These observations support the postulation by Rao and 
McClements (2012) for the presence of Regime II where the Csat of the oil is reached and results 
in a mixture of swollen micelles and nanoemulsion droplets. Fig. 9b showed the presence of 
spherical micelles. The same observation was reported by Garti et al. (2004) and was attributed to 
the higher concentration added of guest molecule in the system which causes a more concave 
curvature toward the oil. In our study, the loratadine concentration was between 25-50% of the oil 





3.10 Stability of nanoemulsions at different temperatures 
The stability of nanoemulsions is an important measure that dictates the shelf life of a given 
formulation. The stability of the optimized nanoemulsions was tested during storage at room 
temperature and at cold temperature for six months as shown in Table 6. For the freshly prepared 
systems containing oleic acid and Tween 80, there was initially a decrease in mean particle 
diameter from around 62 to 43 nm (1:5), 63 to 33 nm (1:7) and 50 to 31 nm (1:10) over the first 
three days of storage. The same behavior was observed with coconut oil nanoemulsions. This 
effect indicates that oil droplets have been fully solubilized within the Tween 80 micelles for an 
extended period as suggested by Rao and McClements (2012). The decrease in the droplet size is 
clearly a transient regime of Ostwald ripening as suggested by Nazarzadeh et al. (2013) and is 
independent of the nature of the change. The ability of Tween 80 to enhance the stability of the 
colloidal dispersions can also be explained to its capacity to produce repulsive steric forces 
between the colloidal particles owing to its comparatively large head group size. From the other 
point of view, we suggest the fabrication of nanoemulsions using different phase inversion 
approaches with short application of ultrasound promoted long-term stability.  
At 25 °C, the mean droplet diameter was noticeably increased with time during storage except for 
CO-10. This indicates that the nanoemulsions were unstable to droplet growth at the highest 
storage temperature near the PIT. This can be ascribed to the fact that the rate of Ostwald ripening 
and/or droplet coalescence in a nanoemulsion rises in the temperature range just below the PIT 
(Chuesiang et al., 2018). This acceleration in coalescence might be attributed to the partial 
dehydration of Tween 80 head groups resulting in relatively low interfacial tension and the 
monolayers become highly flexible, which facilitates the fusion of oil droplets when they collide. 
At 4 °C, there was no significant change in mean droplet diameter throughout storage for the 
nanoemulsions except in CO-10.    
In the case of CO-10, it showed a significant decrease in particle size over time at 25 °C from 23 
to 13 nm. This suggests that higher concentrations of hydrophilic surfactant is effective in 
solubilizing a medium chain triglyceride such as coconut oil. The addition of lipophilic loratadine 
at approximately 50% of the oil phase (acts as ripening inhibitor) exerts an optimal compositional 
effect by reducing the oil’s aqueous solubility, if added together prior to homogenization (Ryu et 
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al., 2018) (Chuesiang et al., 2018), however, this behavior requires further studies. The same effect 
was not observed with OA-10 nanoemulsion.  
Table 6 
Despite the rise in mean particle diameter during storage, all of the nanoemulsions appeared visibly 
stable to creaming throughout the 6-month storage period, due to their small droplet sizes. 
However, we observed that all the nanoemulsions had loratadine crystals formed within 20 days 
after preparation. This can be due to nanoemulsion cooling which resulted in drug supersaturation 
in the oil and/or aqueous phases, which would favor nucleation and crystal growth as proposed by 
Li et al., (2012). Varying parameters such as surfactant concentration, oil type and preparation 
method could not completely prevent loratadine crystal formation beyond 20 days of storage, and 
the same was reported by Li et al., (2012).  
Nanoemulsions have excellent stability against creaming, sedimentation, flocculation and 
coalescence due to small droplet size compared to coarse emulsions. However, they can undergo 
degradation via two well-known distinctive irreversible demulsification processes: coalescence 
and Ostwald ripening. Coalescence occurs due to collision of droplets with each other (Wang et 
al., 2008). The change in droplet size with time can be described by the following equation if the 
instability mechanism is coalescence:  
 
where r is the average droplet radius after time t, r0 is the droplet radius at t = 0, and ω is the 
frequency of rupture per unit surface of the film.  
Ostwald ripening is found to be the main mechanism producing instability in nanoemulsions (Li 
and Chiang, 2012). Ostwald ripening occurs due to the difference in the radius between droplets, 
and the difference in chemical potential of the oil phase between different droplets. In the ripening 
process, larger droplets grow at the expense of smaller ones due to molecular diffusion through 





where r is the average droplet size after time t, C( ) is the bulk phase solubility (the solubility of 
the oil in an infinitely large droplet), γ is the interfacial tension, Vm is the molar volume of the oil, 
D is the diffusion coefficient of the oil in the continuous phase,  is the oil density, and R is the 
gas constant. 
Fig. 10a suggests that there is no linear relationship upon plotting 1/r2 as a function of time and 
indicates that coalescence is not the basic mechanism for the nanoemulsion instability. On the 
other hand, there was a good linear relationship between r3 and time as shown in Fig. 10b indicating 
that the main instability process was indeed the asymptotic regime of Ostwald ripening and 
Brownian-induced coalescence and they are valid for very diluted emulsions where drop 
interactions are negligible (Nazarzadeh et al., 2013). It is worth noting that the presence of 
multimodal distribution as shown in Fig. 6b suggests that flocculation as another mechanism of 
destabilization, was operative with Ostwald ripening in nanoemulsions (Nazarzadeh et al., 2013). 
Nevertheless, in this study, Ostwald ripening only occurred during the initial storage period. After 
6 months of storage, the droplet size of nanoemulsions remained stable indicating that loratadine’s 
ripening inhibitory function with ultrasound was very effective in slowing down the Ostwald 







4. Conclusions  
Stable nanoemulsions containing saturated concentration of loratadine obtained by ultrasound-
assisted two-step phase inversion and cooling-stepwise dilution process, have to the best of our 
knowledge, been reported for the first time in the area of transdermal drug delivery. In addition, 
the use of a drug molecule, loratadine, to function as a ripening inhibitor is reported for the first 
time. The increase in preparation temperature and water volume fraction enhanced the surfactant 
adsorption at the o/w interface and reduced the viscous resistance of the oil phase. As a result, the 
droplet diameter did not exceed 50 nm after the preparation. During the emulsification method, 
the droplet diameter was primarily controlled by the microemulsion framework, and excess water 
only served as a dilution medium. Once nanoemulsions formed, the size distributions remained 
unchanged over the period of 6 months. The increased insolubility of the oil phase as a result of 
loratadine addition in the continuous phase prevented the Ostwald ripening process dramatically. 
The process established in this study is an attractive option for nanoemulsion as this technique 
leads to the production of long-term stability nanoemulsions. Nanoemulsions improved the in vitro 
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Table Captions  
Table 1: Amounts of lipids required to solubilize 50 mg of loratadine in lipid vs. water. 
Table 2: Composition of primary microemulsion concentrates (% w/w) containing 0.3% w/w of 
loratadine. 
Table 3: O/S ratio, droplet volume fraction and surface coverage of droplets of nanoemulsions 
produced by Method 1 and Method 2. 
Table 4: Drug entrapment and drug loading percentages of different formulations. 
Table 5: Particle size measurement, polydispersity index (PDI) and zeta potential of different 
formulations. 








         Table 1 
Lipid Amount (mg) 
Stearic acid 50 
Oleic acid 100 
Cetyl alcohol 150 
Stearyl alcohol 150 
Coconut oil 200 














a OA: Oleic acid, CO: Coconut oil and the number represent the concentration of surfactant used 











Formulationa  Oil Tween 80 Water 
OA-5  0.6 3.0 96.4 
OA-7  0.6 4.2 95.2 
OA-10 0.6 6.0 93.4 
CO-5 1.2 6.0 92.8 
CO-7 1.2 8.4 90.4 













OA-5 / (Method 2) 0.160 0.0072 88 
OA-7 / (Method 2) 0.125 0.0096 98 
OA-10 / (Method 2) 0.090 0.0132 100 
CO-5 / (Method 1) 0.166 0.0144 100 
CO-7 / (Method 1) 0.125 0.0192 100 
CO-10 / (Method 1) 0.090 0.0264  100 
CO-5 / (Method 2) 0.166 0.0144 100 
CO-10 / (Method 2) 0.090 0.0264 100 
a Surface coverage of 100% implies that water is saturated with Tween 80 with excess surfactant 








       Table 4 
Formulation Drug entrapment (%) Drug loading (%) 
OA-5 / (Method 2) 99.21 49.61 
OA-7 / (Method 2) 81.03 40.52 
OA-10 / (Method 2) 86.06 43.03 
CO-5 / (Method 1) 84.99 21.25 
CO-7 / (Method 1) 67.30 16.82 
CO-10 / (Method 1) 76.11 19.03 
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CO-5 / (Method 2) 65.02 16.26 







diameter (nm ± SD) 
PDI 
(nm ± SD) 
Zeta potential 
(Mv ± SD ) 
OA-5 / (Method 2) 43 ± 26 0.19 ± 0.0 -11 ± 6 
OA-7 / (Method 2) 33 ± 3 0.26 ± 0.7 -11 ± 7 
OA-10 / (Method 2) 32 ± 4 0.38 ± 6.9 -8 ± 4 
CO-5 / (Method 1) 15 ± 6 0.26 ± 2.9 -12 ± 3 
CO-7 / (Method 1) 16 ± 3 0.20 ± 0.0 -11 ± 4 
CO-10 / (Method 1) 23 ± 3 0.70 ± 1.0 -11 ± 5 
CO-5 / (Method 2) 30 ± 11 0.47 ± 1.0 -9 ± 4 
CO-7 / (Method 2) 23 ± 8 0.43 ± 8.2 -12 ± 6 









diameter (nm ± SD) 
(25 °C) 
Hydrodynamic 
diameter (nm ± SD) 
(4 °C) 
OA-5 / (Method 2) 101±49 39±31 
OA-7 / (Method 2) 52.±20 37±24 
OA-10 / (Method 2) 51±24 30±27 
CO-5 / (Method 1) 21±5 18±6 
CO-7 / (Method 1) 17±4 20±2 
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Figure 1: Loratadine nanoemulsions prepared with different lipids 
Figure 2: Variation of cloud point of Tween 80 (C17E20) of different concentrations with 
temperature. (●) 0.6%wt, (■) 0.84%wt and (▲) 1.2%wt of Tween 80.  
Figure 3: Variation of PIT of nanoemulsions of different Tween 80 concentrations with 
temperature. (●) 0.6%wt, (■) 0.84%wt and (▲) 1.2%wt. 
Figure 4: Electric conductivity measurements as a function of water concentration (Tween 80 + 
H2O) at 85 °C.  
Figure 5: Phase inversion feasibility domains (PIFD) diagram 
Figure 6: Particle size distribution of (a) OA-7 and (b) CO-5. 
Figure 7: (a) Loratadine release profile for nanoemulsions prepared using oleic acid and different 
Tween 80 ratios: OA-5/ (Method 2) (♦), OA-7/ (Method 2) (■) and OA-10/ (Method 2) (▲). Mean 
± SD (n = 3). 
Figure 7: (b) Loratadine release profile for nanoemulsions prepared using oleic acid and different 
Tween 80 ratios: CO-5/ (Method 1) (♦), CO-7/ (Method 1) (■), CO-10/ (Method 1) (▲) and CO-
10/ (Method 2) (×). Mean ± SD (n = 3). 
Figure 8: (a) Skin permeation of loratadine nanoemulsions in comparison to saturated solution 
prepared using oleic acid and different Tween 80 ratios: OA-5/ (Method 2) (♦), OA-7/ (Method 2) 
(■), OA-10/ (Method 2) (▲) and saturated solution (×). Mean ± SD (n ≥ 3). 
Figure 8: (b) Skin permeation of loratadine nanoemulsions in comparison to saturated solution 
prepared using coconut oil and different Tween 80 ratios: CO-5/ (Method 1) (♦), CO-7/ (Method 
1) (■), CO-10/ (Method 1) (▲) and saturated solution (×). Mean ± SD (n ≥ 3).  
Figure 9: Cryogenic-transmission electron micrograph (Cryo-TEM) of nanoemulsions 
Figure 10: Storage stability of nanoemulsions at 25 °C. (a) 1/r2 as a function of time (a) and r3 as 
a function of time (b) for oleic acid nanoemulsions.  
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Figure 7 (b)  
 
 










































































Figure 8 (b)  
 

















































Figure 10 (a) 
 
 











































Declaration of interests 
 
 The authors declare that they have no known competing financial interests or personal relationships 
that could have appeared to influence the work reported in this paper. 
 
☐The authors declare the following financial interests/personal relationships which may be considered 
as potential competing interests:  
 
 
 
 
 
 
